363 related articles for article (PubMed ID: 32160765)
1. Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation.
Siddiqi SH; Taylor SF; Cooke D; Pascual-Leone A; George MS; Fox MD
Am J Psychiatry; 2020 May; 177(5):435-446. PubMed ID: 32160765
[TBL] [Abstract][Full Text] [Related]
2. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.
Williams LM; Coman JT; Stetz PC; Walker NC; Kozel FA; George MS; Yoon J; Hack LM; Madore MR; Lim KO; Philip NS; Holtzheimer PE
BMC Psychiatry; 2021 Jan; 21(1):35. PubMed ID: 33435926
[TBL] [Abstract][Full Text] [Related]
3. Mapping Symptom Clusters to Circuits: Toward Personalizing TMS Targets to Improve Treatment Outcomes in Depression.
Nestor SM; Blumberger DM
Am J Psychiatry; 2020 May; 177(5):373-375. PubMed ID: 32354264
[No Abstract] [Full Text] [Related]
4. Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity.
Fox MD; Liu H; Pascual-Leone A
Neuroimage; 2013 Feb; 66():151-60. PubMed ID: 23142067
[TBL] [Abstract][Full Text] [Related]
5. A Human Depression Circuit Derived From Focal Brain Lesions.
Padmanabhan JL; Cooke D; Joutsa J; Siddiqi SH; Ferguson M; Darby RR; Soussand L; Horn A; Kim NY; Voss JL; Naidech AM; Brodtmann A; Egorova N; Gozzi S; Phan TG; Corbetta M; Grafman J; Fox MD
Biol Psychiatry; 2019 Nov; 86(10):749-758. PubMed ID: 31561861
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.
Fox MD; Buckner RL; White MP; Greicius MD; Pascual-Leone A
Biol Psychiatry; 2012 Oct; 72(7):595-603. PubMed ID: 22658708
[TBL] [Abstract][Full Text] [Related]
7. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease.
Siddiqi SH; Schaper FLWVJ; Horn A; Hsu J; Padmanabhan JL; Brodtmann A; Cash RFH; Corbetta M; Choi KS; Dougherty DD; Egorova N; Fitzgerald PB; George MS; Gozzi SA; Irmen F; Kuhn AA; Johnson KA; Naidech AM; Pascual-Leone A; Phan TG; Rouhl RPW; Taylor SF; Voss JL; Zalesky A; Grafman JH; Mayberg HS; Fox MD
Nat Hum Behav; 2021 Dec; 5(12):1707-1716. PubMed ID: 34239076
[TBL] [Abstract][Full Text] [Related]
8. Targeting Symptom-Specific Networks With Transcranial Magnetic Stimulation.
Siddiqi SH; Fox MD
Biol Psychiatry; 2024 Mar; 95(6):502-509. PubMed ID: 37979642
[TBL] [Abstract][Full Text] [Related]
9. Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS.
Avissar M; Powell F; Ilieva I; Respino M; Gunning FM; Liston C; Dubin MJ
Brain Stimul; 2017; 10(5):919-925. PubMed ID: 28747260
[TBL] [Abstract][Full Text] [Related]
10. Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.
Weigand A; Horn A; Caballero R; Cooke D; Stern AP; Taylor SF; Press D; Pascual-Leone A; Fox MD
Biol Psychiatry; 2018 Jul; 84(1):28-37. PubMed ID: 29274805
[TBL] [Abstract][Full Text] [Related]
11. Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity.
Li X; Large CH; Ricci R; Taylor JJ; Nahas Z; Bohning DE; Morgan P; George MS
Psychiatry Res; 2011 Nov; 194(2):141-8. PubMed ID: 21924874
[TBL] [Abstract][Full Text] [Related]
12. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder.
Philip NS; Barredo J; van 't Wout-Frank M; Tyrka AR; Price LH; Carpenter LL
Biol Psychiatry; 2018 Feb; 83(3):263-272. PubMed ID: 28886760
[TBL] [Abstract][Full Text] [Related]
13. Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression.
Cash RFH; Weigand A; Zalesky A; Siddiqi SH; Downar J; Fitzgerald PB; Fox MD
Biol Psychiatry; 2021 Nov; 90(10):689-700. PubMed ID: 32800379
[TBL] [Abstract][Full Text] [Related]
14. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
Downar J; Geraci J; Salomons TV; Dunlop K; Wheeler S; McAndrews MP; Bakker N; Blumberger DM; Daskalakis ZJ; Kennedy SH; Flint AJ; Giacobbe P
Biol Psychiatry; 2014 Aug; 76(3):176-85. PubMed ID: 24388670
[TBL] [Abstract][Full Text] [Related]
15. Neuromodulation for the treatment of functional neurological disorder and somatic symptom disorder: a systematic review.
Oriuwa C; Mollica A; Feinstein A; Giacobbe P; Lipsman N; Perez DL; Burke MJ
J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):280-290. PubMed ID: 35115389
[TBL] [Abstract][Full Text] [Related]
16. White matter integrity and functional predictors of response to repetitive transcranial magnetic stimulation for posttraumatic stress disorder and major depression.
Barredo J; Bellone JA; Edwards M; Carpenter LL; Correia S; Philip NS
Depress Anxiety; 2019 Nov; 36(11):1047-1057. PubMed ID: 31475432
[TBL] [Abstract][Full Text] [Related]
17. Low-Frequency Transcranial Magnetic Stimulation (LF-TMS) in Treating Depression in Patients With Impaired Cognitive Functioning.
Schaffer DR; Okhravi HR; Neumann SA
Arch Clin Neuropsychol; 2021 Jul; 36(5):801-814. PubMed ID: 33140093
[TBL] [Abstract][Full Text] [Related]
18. Default mode network mechanisms of transcranial magnetic stimulation in depression.
Liston C; Chen AC; Zebley BD; Drysdale AT; Gordon R; Leuchter B; Voss HU; Casey BJ; Etkin A; Dubin MJ
Biol Psychiatry; 2014 Oct; 76(7):517-26. PubMed ID: 24629537
[TBL] [Abstract][Full Text] [Related]
19. A landmark-based approach to locate symptom-specific transcranial magnetic stimulation targets of depression.
Du R; Zhou Q; Hu T; Sun J; Hua Q; Wang Y; Zhang Y; He K; Tian Y; Ji GJ; Wang K
Front Psychol; 2022; 13():919944. PubMed ID: 36118495
[TBL] [Abstract][Full Text] [Related]
20. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.
Croarkin PE; Elmaadawi AZ; Aaronson ST; Schrodt GR; Holbert RC; Verdoliva S; Heart KL; Demitrack MA; Strawn JR
Neuropsychopharmacology; 2021 Jan; 46(2):462-469. PubMed ID: 32919400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
